Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Trinity Biotech ADR | 26 | 0 | 1 | 0 | €0.41 | - | - |
| Valneva SE | 1 | 0 | 0 | 0 | €3.51 | - | - |
| Pro-Dex Inc. | 11 | 0 | 0 | 0 | €16.70 | - | - |
| Veracyte Inc. | 1 | 0 | 0 | 0 | €28.40 | - | - |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €4.26 | - | - |
| Stratec SE | 2 | 0 | 0 | 0 | €42.00 | - | - |
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | €23.20 | - | - |
| Immunogen Inc. | 3 | 0 | 0 | 0 | €28.97 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €40.80 | - | - |
| Omeros Corp. | 2 | 3 | 0 | 0 | €3.70 | - | - |
| Brainstorm Cell | 2 | 0 | 0 | 0 | €0.27 | €1.84 | 574.128% |
| ProQR Therapeutics N.V. | 7 | 2 | 0 | 0 | €2.03 | €2.32 | 14.325% |
| Rockwell Medical Inc. | 2 | 0 | 1 | 0 | €2.10 | €3.00 | 43.130% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.51 | €3.00 | 99.071% |
| Cytosorbents Corp. | 3 | 0 | 0 | 0 | €0.81 | €3.25 | 300.974% |
| Cerus Corp. | 4 | 0 | 0 | 0 | €1.99 | €3.26 | 63.469% |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.22 | €3.64 | 199.951% |
| Sangamo Therapeutics Inc. | 11 | 16 | 2 | 3 | €0.83 | €3.70 | 343.685% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 0 | 0 | €2.31 | €4.16 | 79.983% |
| Heron Therapeutics Inc. | 12 | 1 | 1 | 0 | €1.69 | €4.60 | 173.056% |
| Geron Corp. | 16 | 0 | 2 | 0 | €4.04 | €5.54 | 37.163% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €2.70 | €5.55 | 105.689% |
| Pulmatrix Inc. | 2 | 1 | 1 | 0 | €1.92 | €6.08 | 216.510% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | €3.36 | €6.45 | 92.042% |
| Inogen Inc. | 1 | 2 | 0 | 1 | €10.90 | €6.53 | -40.050% |